Peer Review History
| Original SubmissionMarch 17, 2023 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
Dear Dr. Li, Thank you very much for submitting your manuscript "Novel secreted STPKLRR from Vibrio splendidus AJ01 promotes pathogen internalization via mediating tropomodulin phosphorylation dependent cytoskeleton rearrangement" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. Reviewer 1 and 4 complain that the multiple figure panels are too small. The Figures all need attention so that it is possible to properly read the text on the Y and X-axis and all photos (Figures) must be enlarged so they can be read and studied without any magnification. There are some experiments proposed especially by Reviewer 1 but also one experiment on lysosomal activity suggested by Reviewer 3 that need to be done unless the authors can convincingly argue that these experiments are not necessary. It is important that all comments made by each reviewer are properly dealt with and if the authors disagree with any recommendation or criticism they have to deliver good arguments for doing this. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts. Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Kenneth Söderhäll Guest Editor PLOS Pathogens Karla Satchell Section Editor PLOS Pathogens Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens *********************** Reviewer 1 and 4 complain that the multiple figure panels are too small. The Figures all need attention so that it is possible to properly read the text on the Y and X-axis and all photos (Figures) must be enlarged so they can be read and studied without any magnification. There are some experiments proposed especially by Reviewer 1 but also one experiment on lysosomal activity suggested by Reviewer 3 that need to be done unless the authors can convincingly argue that these experiments are not necessary. It is important that all comments made by each reviewer are properly dealt with and if the authors disagree with any recommendation or criticism they have to deliver good arguments for doing this. Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: In this paper the authors identify a leucine-rich repeat-containing serine/threonine protein kinase from Vibrio splendidus AJ01. The authors use several methods to demonstrate that this protein is used by the pathogen to phosphorylate Tropomodulin (Tmod) in Apostichopus japonicus, leading to that Tmod dissociate from actin which result in rearrangement of the cytoskeleton enabling internalization of the pathogenic AJ01 bacterium. This is an important finding in order to understand the infection biology of V. splendidus. The findings are new and very interesting and is a continuation of previous studies by this group, and the authors have done a proper and thorough coverage of previous relevant studies in the literature. Reviewer #2: This report is an important contribution to our understanding about the detailed mechanisms used by Vibrio splendidus to enter Apostichopus japonicus coelomocytes. The authors provide clear evidence for the role of the serine/threonine kinase activity of STPKLRR, to phosphorylate tropomodulin in the coelomocyte cytoplasm, in order to favor V. splendidus internalization by phagocytosis most likely through macropinocytosis and actin-dependent endocytic pathways. Tropomodulin in Apostichopus japonicus was first characterized in the group’s previous work in JBC, which plays an important role in coelomocytes apoptosis. Based on the first publication, the authors identify a Tmod-targeted mechanism of cell entry in Vibrio splendidus with a considerable number of assays. This makes sense from a pathogen-host interaction perspective. The role of Tmod in stabilizing the cytoskeleton seems to be its own job. However, Tmod plays a role in apoptosis, which is not discussed in the manuscript. The multifunctionality of a single gene is not surprising, but the involvement of pathogen-host interaction at the same time is worthy of attention in the follow-up research of the authors. However, there are still some details in the manuscript needed to be addressed. Reviewer #3: This manuscript mainly revealed the mechanisms that a novel Vibrio splendidus AJ01 Type III secretion system effector of STPKLRR could specifically interact with AjTmod, causing the phosphorylation of AjTmod at serine 52, thus reducing the binding stability between AjTmod and actin. After AjTmod dissociated from actin, the F-actin/G-actin ratio decreased to induce cytoskeletal rearrangement, which in turn promoted the internalization of AJ01. Supported by a large number of experimental data, this manuscript answers how AJ01 breaks the AjTmod-stabilized cytoskeleton for internalization from fine details. Reviewer #4: This is an interesting study which adds to advancing our understanding of TSS3 mechanisms of Vibrio splendidus in the host Apostichopus. The study is comprehensive, with a full range of different advanced methods being employed to provide insights of mechanisms. The general execution and scholarship appear sound. However, the resolution and size (and complexity) of the multi panel figures completely defeats review. Image resolution is so poor - it is impossible to judge the detail of what is being shown, or follow the interpretation or verify claims. I would advise images are submitted at higher resolution, and would actually encourage the submission of simpler figures with fewer panels per composite figure. ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: The data partly support the conclusions, but some more controls and/or explanations are needed, since some results are confusing. The authors have to explain their results in a clearer way and not use so many panels in each figure. Most of the panels in the figures are far too small and the text is nearly impossible to read, and therefore very difficult to evaluate. This is also true for the some of the supplementary figures. For example, figure S6A-C are not readable so either remove or magnify. For figure 1D an explanation is needed in the legend about the details of the upper and lower panels. The figure should indicate His-STPKLRR and not only SPKLRR. Moreover, the pattern of the lanes in the blot for His-staining differ a lot from the blots for GST staining. Is the same amount of protein loaded on these gels? Please indicate the loading amount. The panels in figure 1 is also very small making them difficult to read and evaluate. I suggest that the authors place figure 1A-C as a supplement, and enlarge figure 1D. Figure 2D is to low resolution to be understandable. It is not possible to understand what the arrow points at. There are too many panels in this figure as well. In figure 2G the number of intracellular AJ01 is shown, but to what are these figures related? Is it per gram tissue or something else? Another question is to the following experiments where coelomocytes are used. Are these cells the main target of this bacterium? In figure 2E second row the bacterium is in a phagosome, but is it killed there or does it multiply in coelomocytes? Figure 3 has too many panels, which are too small to be readable. Magnification does make the panels blurry. The text in figure 3E-H is impossible to read. Figure 3A-B shows secretion of STPKLRR and uptake (?) into coelomoctes. The legend is a bit unclear. In 3A marker lanes for the western blot is needed, and for 3B the legend should indicate that the pictures show coelomocytes and internalization of STPKLRR (if this is correct). Figure 3D shows coelomocyte extract from cell infected with the different mutants and “wild type” AJ01 strains used in figure 2, and STPKLRR is only found in the wild type infected cells or the “restored” DeltaSTPKLRR::pMPSTPKLRR infected cells. However, why is DnaK detected in the cytoplasm of all coelomocytes if was necessary for bacterial internalization as shown in figure 2? Figure 3E-G: Explain that these figures show the effect of the T3SS inhibitors on bacterial growth (if this is correct). These panels could be moved to supplemental material. The DnaK panels in figure H-J looks completely empty (non loaded), and moreover the non-existent variability of the band intensity shown in the diagrams 3H-J looks very strange. Is it really possible to get nearly identical blots from three different biological replications? What does Gary value mean? I am a bit concerned over figure 4A (and 4B), since the phosphorylated bands look pasted, and have moved in a straight manner compared to the non-phosphorylated proteins. The other panels in figure 4, except for E, F and L are too small to evaluate. The concentrations used in figure 4K are not visible, and are important to judge the results. In figure 5H the total amount of actin varies between time points. Is this correct? Reviewer #2: The morphology of intracellular bacteria in the second and fifth panels of Figure 2E is obviously different. Why is the case? Is this due to the introduction of the vector or other bacteria? If not, some plausible explanation is needed to demonstrate the possible cause of the intracellular morphological changes in Vibrio splendidus. Reviewer #3: 1. Is STPKLRR located on the surface of AJ01? How does AJ01 expose STPKLRR to bind Tmod during internalization? 2. Does STPKLRR-mediated AJ01 internalization promotes the phagocytosis of AJ01? Phagocytosis is a strategy for eliminating pathogens, but STPKLRR-mediated AJ01 internalization promotes AJ01 infection, which seems to contradict each other in this manuscript. It is recommended to test lysosomal activity. Reviewer #4: I would not recommend that further experiments are necessary. ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: The authors need to improve the quality of all the small panels and arrange the paper in a readable way. The English also needs professional editing. Reviewer #2: - Line 61: The provided references of MARTX in Vibrio cholerae are wrong. Please provide the correct references. - Line 77: "Tmod, the only known capping protein of F-actin" is inaccurate. It is the only pointed (minus) end-capping protein. - Check spellings: β-Tubulin or β-tubulin? It should be unified. In Fig. 5, coleomocytes should be corrected to coelomocytes. - In Fig. 2 and Fig. 3, there are some panels with small text. They are difficult for a reader to judge. - Figure S6 can better connect the logic of the manuscript. It is suggested to move it to the main text of the manuscript. Reviewer #3: 1. Fig 3C, the luminance of DAPI is inconsistent. Is the setting of fluorescence parameters inconsistent? In addition, STPKLRR seems to affect the expression of Tmod, but this experiment is not mentioned in this paper. 2. Fig 4A, lacking of internal reference, so there is no comparability between different experimental groups. 3. Fig4F, it is recommended to add STPKLRR signal. 4. Fig5, although F-actin/G-actin ratio indicates cytoskeleton rearrangement, it is suggested to add immunofluorescence assay to observe cytoskeleton changes. Reviewer #4: Resolution of figures must be dramatically improved. For example, the histopathology shown in figure 2 is impossible to judge. E.g. figure 4 is too small, and too low resolution to follow. Etc. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols
|
| Revision 1 |
|
Dear Dr. Li, We are pleased to inform you that your manuscript 'Novel secreted STPKLRR from Vibrio splendidus AJ01 promotes pathogen internalization via mediating tropomodulin phosphorylation dependent cytoskeleton rearrangement' has been provisionally accepted for publication in PLOS Pathogens. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Kenneth Söderhäll Guest Editor PLOS Pathogens Karla Satchell Section Editor PLOS Pathogens Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens *********************************************************** Reviewer Comments (if any, and for reference): Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: This is a revised manuscript and the authors have responded to all questions in an accurate way. The paper is very interesting and the authors present new valuable information about Vibrio infections. Reviewer #2: The manuscript has been revised according to the reviewer's comments. Reviewer #3: The findings in this study are interesting for the host-pathogens interaction in invertebrates. Reviewer #4: This revised manuscript has addressed my main (and only) criticism of poor image quality which made initial assessment impossible. ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: None. Reviewer #2: No Reviewer #3: The key experiments have been added. Reviewer #4: None ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: The figures have been changed and some panels have been moved to supplement. However, I think still that the figures contain to many small panels, and are very difficult to read without very magnification. Moreover they do not fulfil the requirement from PLoS Pathogens instructions, where the size limit is 2625 pixel width at 300 dpi. The authors have made more than 2,5 as large figures in order to get all small panels into the same figure. Please read instructions and make more clear and readable figures. For figure 2: Add the explanation for figure 2F in the figure legend: The number of intracellular bacteria represented the number of intracellular bacteria in each well of a 6-well plate, and the number of cells per well was about106. Reviewer #2: No Reviewer #3: Ok for this reviewer. Reviewer #4: None ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Hai-peng Liu Reviewer #4: No |
| Formally Accepted |
|
Dear Dr. Li, We are delighted to inform you that your manuscript, "Novel secreted STPKLRR from Vibrio splendidus AJ01 promotes pathogen internalization via mediating tropomodulin phosphorylation dependent cytoskeleton rearrangement," has been formally accepted for publication in PLOS Pathogens. We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .